Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 15 Oct 2024 08:20 CEST |
TOTALENERGIES | TotalEnergies: Third Quarter 2024: Main Indicators | 60101000 Integrated Oil and Gas | Other subject |
| 15 Oct 2024 08:15 CEST |
ARCTIC BIOSCIENCE AS | Arctic Bioscience - Invitasjon til webcast - HeROPA utlesning | 45102020 Food Products | Annen informasjonspliktig regulatorisk informasjon |
| 15 Oct 2024 08:15 CEST |
ARCTIC BIOSCIENCE AS | Arctic Bioscience - Invitation to webcast - HeROPA read-out | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Oct 2024 08:00 CEST |
ORKLA ASA | Invitasjon til presentasjon av Orklas resultater for 3. kvartal 2024 tirsdag 29. oktober | 45102020 Food Products | Annen informasjonspliktig regulatorisk informasjon |
| 15 Oct 2024 08:00 CEST |
ORKLA ASA | Invitation to presentation of Orkla's third quarter 2024 results, Tuesday 29 October | 45102020 Food Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Oct 2024 08:00 CEST |
Equinor ASA | Equinor ASA: Tilbakekjøp av egne aksjer | 60101000 Integrated Oil and Gas | Utsteders meldeplikt ved handel i egne aksjer |
| 15 Oct 2024 08:00 CEST |
Equinor ASA | Equinor ASA: Share buy-back | 60101000 Integrated Oil and Gas | Acquisition or disposal of the issuer’s own shares |
| 15 Oct 2024 08:00 CEST |
NORAM DRILLING AS | NorAm Drilling AS - Ex cash distribution USD 0.04 today | 60101030 Oil Equipment and Services | Ex Date |
| 15 Oct 2024 08:00 CEST |
ADOCIA | ADOCIA Announces Patenting Stable Combinations of GLP-1 and Amylin Analogs for the Treatment of Obesity and Diabetes Using Its BioChaperone® Platform | 20103010 Biotechnology | Other subject |
| 15 Oct 2024 08:00 CEST |
ONCODESIGN PRECISION MEDICINE | OPM Announces Poster Presentation on OPM-101, a RIPK2 Kinase Inhibitor, in Healthy Volunteers at UEG Week 2024 Conference | 20103010 Biotechnology | Products and services |
| 15 Oct 2024 08:00 CEST |
ING GROEP N.V. | ING completes share buyback programme | 30101010 Banks | Other subject |
| 15 Oct 2024 08:00 CEST |
LOKOTECH GROUP AS | Lokotech Group invites to fireside chat Tuesday 22nd of October 2024 | 10102010 Semiconductors | Non-regulatory press releases |
| 15 Oct 2024 08:00 CEST |
ADOCIA | ADOCIA annonce breveter des combinaisons stables d’analogues de GLP-1 et d’amyline pour le traitement de l’obésité et du diabète grâce à sa plateforme BioChaperone® | 20103010 Biotechnology | Other subject |
| 15 Oct 2024 08:00 CEST |
Sparebanken Sogn og Fjordane | Namneendring til SpareBank 1 Sogn og Fjordane | - | Annen informasjonspliktig regulatorisk informasjon |
| 15 Oct 2024 08:00 CEST |
ONCODESIGN PRECISION MEDICINE | OPM annonce la présentation d’un poster sur OPM-101, inhibiteur de la kinase RIPK2, chez les volontaires sains lors du congrès de l’UEG Week 2024 | 20103010 Biotechnology | Products and services |
| 15 Oct 2024 07:30 CEST |
ATOS | Atos appoints Philippe Salle Chairman of the Board of Directors with effect from October 14, 2024 and Chairman and Chief Executive Officer from February 01, 2025 | 10101010 Computer Services | General meeting / Board Meeting |
| 15 Oct 2024 07:30 CEST |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
| 15 Oct 2024 07:30 CEST |
MAAT PHARMA | MaaT Pharma Completes Recruitment of its ARES Phase 3 Trial for MaaT013 to Treat Acute Graft-versus-Host Disease | 20103010 Biotechnology | Other subject |
| 15 Oct 2024 07:30 CEST |
ONWARD MEDICAL | ONWARD® Medical signe un accord avec le CEA pour obtenir les droits exclusifs de la technologie d’interface cerveau machine (BCI) WIMAGINE® de Clinatec | 20101025 Health Services | - |
| 15 Oct 2024 07:30 CEST |
ATOS | Atos nomme Philippe Salle Président du Conseil d’administration à compter du 14 octobre 2024 et Président-Directeur général à compter du 1er février 2025 | 10101010 Computer Services | General meeting / Board Meeting |
| 15 Oct 2024 07:30 CEST |
BOUSSARD GAVAUDAN HOLD LTD GBP | BGHL (GBP): NAV(s) | 30204000 Closed End Investments | Other subject |
| 15 Oct 2024 07:30 CEST |
MAAT PHARMA | MaaT Pharma annonce la fin du recrutement de son essai de Phase 3 ARES pour MaaT013 dans le traitement de la maladie aiguë du greffon contre l'hôte | 20103010 Biotechnology | Other subject |
| 15 Oct 2024 07:30 CEST |
ONWARD MEDICAL | ONWARD® Medical Signs Agreement with CEA for Exclusive Rights to Clinatec’s WIMAGINE® Brain-Computer Interface (BCI) Technology | 20101025 Health Services | - |
| 15 Oct 2024 07:09 CEST |
INPOST S.A. | InPost increased its stake in Menzies to 100% and now is taking full control over logistics operations in the UK | 50206040 Delivery Services | Mergers, Acquiqitions, Transferts |
| 15 Oct 2024 07:07 CEST |
SOILTECH ASA | Soiltech awarded contract with Equinor | 65102030 Water | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Oct 2024 07:01 CEST |
BIOMERIEUX | bioMérieux receives CE-marking for VIDAS® VITAMIN B12 TOTAL, a blood test to measure total Vitamin B12 concentration | 20102010 Medical Equipment | Other subject |
| 15 Oct 2024 07:01 CEST |
BIOMERIEUX | bioMérieux obtient le marquage CE du test sanguin VIDAS® VITAMIN B12 TOTAL mesurant la concentration totale de vitamine B12 | 20102010 Medical Equipment | Other subject |
| 15 Oct 2024 07:00 CEST |
NORSE ATLANTIC ASA | Norse Atlantic ASA: Extended maturity of shareholder loan | 40501010 Airlines | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Oct 2024 07:00 CEST |
Veidekke ASA | Veidekke: Ser lys i enden av tunnelen for det skandinaviske entreprenørmarkedet | 50101010 Construction | Ikke-informasjonspliktige pressemeldinger |
| 15 Oct 2024 07:00 CEST |
Veidekke ASA | Veidekke: Sees light at the end of the tunnel for the Scandinavian contracting markets | 50101010 Construction | Non-regulatory press releases |
| 15 Oct 2024 07:00 CEST |
MAGNORA | Magnora ASA Q3 2024: Dividends, growth and diversification | 60102020 Renewable Energy Equipment | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Oct 2024 07:00 CEST |
MAGNORA | Magnora ASA capital distribution | 60102020 Renewable Energy Equipment | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Oct 2024 07:00 CEST |
LIFECARE ASA | Lifecare ASA: Last day of application period | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Oct 2024 07:00 CEST |
HOEGH AUTOLINERS ASA | Höegh Autoliners ASA: Invitation to presentation of third quarter 2024 results | 50206030 Marine Transportation | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Oct 2024 07:00 CEST |
HERMANA HOLDING ASA | Hermana Holding ASA: Q3 2024 Report | 60101030 Oil Equipment and Services | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Oct 2024 07:00 CEST |
ARGENX SE | argenx Highlights Data Showing Patient Impact Across Multiple Immunology Programs at 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and Myasthenia Gravis Foundation of America Scientific Sessions | 20103010 Biotechnology | Other subject |
| 15 Oct 2024 07:00 CEST |
Link Mobility Group Holding | LINK Mobility - Transactions made under new Company share repurchase program | 10101015 Software | Acquisition or disposal of the issuer’s own shares |
| 15 Oct 2024 06:30 CEST |
Mowi ASA | Mowi ASA (OSE:MOWI): Q3 2024 Trading update | 45102010 Farming, Fishing, Ranching and Plantations | Inside information |
| 15 Oct 2024 06:30 CEST |
ARCTIC FISH HOLDING AS | Arctic Fish (AFISH): Q3-24 Trading update | 45102010 Farming, Fishing, Ranching and Plantations | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Oct 2024 00:06 CEST |
NORTEM BIOGROUP | 2023 financial report with audited accounts | 55201000 Chemicals: Diversified | Commercial results |
| 14 Oct 2024 22:30 CEST |
COTY INC | Coty Announces Preliminary First Quarter Results and Reiterates FY25 Adjusted EBITDA Outlook for +9-11% YoY Growth, Supporting Stronger EBITDA Margin Expansion | 40204035 Cosmetics | Sales |
| 14 Oct 2024 22:30 CEST |
DBV TECHNOLOGIES | Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024 | 20103010 Biotechnology | Other subject |
| 14 Oct 2024 22:30 CEST |
DBV TECHNOLOGIES | Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 septembre 2024 | 20103010 Biotechnology | Other subject |
| 14 Oct 2024 20:23 CEST |
Schibsted ASA | Schibsted ASA (SCHA/SCHB) - Repurchase of own shares | 10101020 Consumer Digital Services | Acquisition or disposal of the issuer’s own shares |
| 14 Oct 2024 20:02 CEST |
B.C.P.-BCO COMERCIAL PORTUGUES | Banco Comercial Português, S.A. informs about issue of senior preferred debt securities eligible for MREL | 30101010 Banks | Other subject |
| 14 Oct 2024 20:02 CEST |
B.C.P.-BCO COMERCIAL PORTUGUES | Banco Comercial Português, S.A. informa sobre emissão de títulos de dívida sénior preferencial elegível para MREL | 30101010 Banks | Other subject |
| 14 Oct 2024 19:45 CEST |
INVENTIVA | Inventiva announces the availability of a prospectus in connection with its financing through the issuance of ordinary shares and pre-funded warrants | 20103010 Biotechnology | Other subject |
| 14 Oct 2024 19:45 CEST |
INVENTIVA | Inventiva annonce la mise à disposition d'un prospectus dans le cadre de son financement par l’émission d’actions ordinaires et de bons de souscription d’action préfinancés | 20103010 Biotechnology | Other subject |
| 14 Oct 2024 19:16 CEST |
IKONISYS | Ikonisys Completed a Capital Increase Through a Private Placement | 20102010 Medical Equipment | Share introduction and issues |
| 14 Oct 2024 19:16 CEST |
IKONISYS | Ikonisys a finalisé une augmentation de capital par le biais d'un placement privé | 20102010 Medical Equipment | Share introduction and issues |